United Therapeutics
Top stories
Latest
- Insider Selling: United Therapeutics (NASDAQ:UTHR) CEO Sells $5,476,465.00 in Stockdailypolitical.com · 2026-10-02 21:21 UTC · story
- Head-To-Head Contrast: United Therapeutics (NASDAQ:UTHR) vs. Emergent Biosolutions (NYSE:EBS)themarketsdaily.com · 2026-10-02 13:52 UTC · story
- United Therapeutics Prevails In Patent Litigation Against Liquidiarttnews.com · 2026-10-01 04:34 UTC · story
- United Therapeutics (UTHR): Goldman Says Sell As The Base Business Shrinks, But 2027 Holds Real Catalystsinsidermonkey.com · 2026-09-29 02:15 UTC · story